Francesco Albano

71PUBLICATIONS
158CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Aug 27, 2026
The Dysregulation of the Integrated Stress Response in Leukemic Stem Cells as a Marker of Treatment Sensitivity in Acute Myeloid Leukemia.

|Jul 08, 2026
Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemia.

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Jul 15, 2025
RUNX1A isoform is overexpressed in acute myeloid leukemia and is associated with FLT3 internal tandem duplications.

Cosimo Cumbo, Francesco Tarantini, Elisa Parciante

|Mar 28, 2024
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.

Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò

Pageof 12

Frequent Collaborators

15 joint publications

Pellegrino Musto

12 joint publications

Cosimo Cumbo

7 joint publications

Francesco Passamonti

7 joint publications

Alessandra Iurlo